India
# |
Name |
Cash and Short-Term Investments |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 758.32 M
|
March 31, 2024 | USD 13.57 | -0.25% |
|
India |
|
2 |
USD 222.61 M
|
March 31, 2024 | USD 25.14 | -2.56% |
|
India |
|
3 |
USD 199.50 M
|
March 31, 2024 | USD 17.54 | 2.44% |
|
India |
|
4 |
USD 62.70 M
|
March 31, 2024 | USD 18.21 | -3.37% |
|
India |
|
5 |
USD 18.74 M
|
March 31, 2024 | USD 4.72 | -3.66% |
|
India |
|
6 |
USD 3.07 M
|
March 31, 2024 | USD 11.74 | -1.33% |
|
India |
|
7 |
USD 1.83 M
|
March 31, 2024 | USD 21.37 | -1.96% |
|
India |
The Vaccines company in India with the highest Cash and Short-Term Investments is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD 758.32 M.
The Vaccines company in India with the lowest Cash and Short-Term Investments is Hester Biosciences Limited (NSE: HESTERBIO.NS) at USD 1.83 M.
The top 10 Vaccines companies in India by Cash and Short-Term Investments are Aurobindo Pharma Limited, GlaxoSmithKline Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Panacea Biotec Limited, Vimta Labs Limited and Hester Biosciences Limited.
The bottom 10 Vaccines companies in India by Cash and Short-Term Investments are Hester Biosciences Limited, Vimta Labs Limited, Panacea Biotec Limited, Wockhardt Limited, Glenmark Pharmaceuticals Limited, GlaxoSmithKline Pharmaceuticals Limited and Aurobindo Pharma Limited.